BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 26152693)

  • 1. Effect of glaucoma medications on 24-hour intraocular pressure-related patterns using a contact lens sensor.
    Mansouri K; Medeiros FA; Weinreb RN
    Clin Exp Ophthalmol; 2015 Dec; 43(9):787-95. PubMed ID: 26152693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-four-Hour Intraocular Pressure-Related Patterns from Contact Lens Sensors in Normal-Tension Glaucoma and Healthy Eyes: The Exploring Nyctohemeral Intraocular pressure related pattern for Glaucoma Management (ENIGMA) Study.
    Kim YW; Kim JS; Lee SY; Ha A; Lee J; Park YJ; Kim YK; Jeoung JW; Park KH
    Ophthalmology; 2020 Nov; 127(11):1487-1497. PubMed ID: 32417391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
    García-López A; Paczka JA; Jiménez-Román J; Hartleben C
    BMC Ophthalmol; 2014 Dec; 14():161. PubMed ID: 25527295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-four-hour intraocular pressure patterns in patients with thyroid eye disease.
    Parekh AS; Mansouri K; Weinreb RN; Tafreshi A; Korn BS; Kikkawa DO
    Clin Exp Ophthalmol; 2015 Mar; 43(2):108-14. PubMed ID: 25132194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy.
    Liu JH; Medeiros FA; Slight JR; Weinreb RN
    Ophthalmology; 2009 Mar; 116(3):449-54. PubMed ID: 19157559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of continuous 24-hour intraocular pressure patterns in glaucoma.
    Mansouri K; Liu JH; Weinreb RN; Tafreshi A; Medeiros FA
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8050-6. PubMed ID: 23139273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours.
    Liu JHK; Slight JR; Vittitow JL; Scassellati Sforzolini B; Weinreb RN
    Am J Ophthalmol; 2016 Sep; 169():249-257. PubMed ID: 27457257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC; Konstas AG; Nelson LA; Kruft B
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual Field Change and 24-Hour IOP-Related Profile with a Contact Lens Sensor in Treated Glaucoma Patients.
    De Moraes CG; Jasien JV; Simon-Zoula S; Liebmann JM; Ritch R
    Ophthalmology; 2016 Apr; 123(4):744-53. PubMed ID: 26854032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C; Oksüz H
    Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 24-hour intraocular pressure rhythm in young healthy subjects evaluated with continuous monitoring using a contact lens sensor.
    Mottet B; Aptel F; Romanet JP; Hubanova R; Pépin JL; Chiquet C
    JAMA Ophthalmol; 2013 Dec; 131(12):1507-16. PubMed ID: 24158696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
    Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M
    PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intereye Symmetry of 24-Hour Intraocular Pressure-related Patterns in Untreated Glaucoma Patients Using a Contact Lens Sensor.
    Mansouri K; Gillmann K
    J Glaucoma; 2020 Aug; 29(8):666-670. PubMed ID: 32487950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study.
    Brandt JD; Sall K; DuBiner H; Benza R; Alster Y; Walker G; Semba CP;
    Ophthalmology; 2016 Aug; 123(8):1685-1694. PubMed ID: 27157843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian intraocular pressure patterns in healthy subjects, primary open angle and normal tension glaucoma patients with a contact lens sensor.
    Agnifili L; Mastropasqua R; Frezzotti P; Fasanella V; Motolese I; Pedrotti E; Di Iorio A; Mattei PA; Motolese E; Mastropasqua L
    Acta Ophthalmol; 2015 Feb; 93(1):e14-21. PubMed ID: 24720477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Invernizzi T; Bottoli A; Autelitano A
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2566-73. PubMed ID: 10937568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of continuous 24-hour intraocular pressure monitoring for assessment of prostaglandin-induced pressure reduction in glaucoma.
    Holló G; Kóthy P; Vargha P
    J Glaucoma; 2014 Jan; 23(1):e6-12. PubMed ID: 24370812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Therapeutic IOP-lowering Interventions on the 24-hour Ocular Dimensional Profile Recorded With a Sensing Contact Lens.
    Cutolo CA; De Moraes CG; Liebmann JM; Mansouri K; Traverso CE; Ritch R;
    J Glaucoma; 2019 Mar; 28(3):252-257. PubMed ID: 30640804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
    Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial.
    Fechtner RD; Myers JS; Hubatsch DA; Budenz DL; DuBiner HB
    Eye (Lond); 2016 Oct; 30(10):1343-1350. PubMed ID: 27367743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.